MKI67 and neuroendocrine carcinoma: This is also reflected by a relatively low median Ki67 of 50% (median Ki67 30% in NET G3 and 70% in NEC), whereas in the NORDIC NEC cohort, 53% of patients had Ki 67 values ≥ 55%.